Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 2:17:2761-2772.
doi: 10.2147/PPA.S431719. eCollection 2023.

Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study

Maha Fayez Albogami  1 , Muneer S AlJomaie  2 , Saad Saleh Almarri  3 , Sultan Al-Malki  4 , Shadi Tamur  4 , Maryam Aljaid  4 , Abdullah Khayat  4 , Ahmad Alzahrani  4
Affiliations

Topical Corticosteroid Phobia Among Parents of Children with Atopic Dermatitis (Eczema)- A Cross-Sectional Study

Maha Fayez Albogami et al. Patient Prefer Adherence. .

Abstract

Background: Anxiety about using topical corticosteroids (TCS) for childrens among parents and caretakers is a common cause of treatment failure and an overall decline in the child's quality of life. The purpose of this study was to examine the perspectives and worries of parents of Atopic dermatitis (AD) children regarding TCS. Additionally, we investigate the degree of phobia in relation to the use of the TCS.

Materials and methods: A convenience sample of 301 parents of children who had been identified with atopic dermatitis from two hospitals in Taif city were enrolled in this study. Parents who chose to participate were sent a questionnaire measuring their level of fear of TCS using the TOPICOP© scale, which also included inquiries about their demographics and clinical characteristics. Multivariate analysis was used to determine what factors influence people's overall levels of fear.

Results: The median global TOPICOP score was 66.6% (IQR 60.4-75%), SD 12.83%, which showed that nearly two-thirds of the participants showed corticosteroid phobia. A multifactorial ANOVA model showed that parents who had a female child with AD and mothers who had experienced drug allergies had a significant influence on TOPICOP scores (P<0.05).

Conclusion: Topical corticosteroid phobia is widespread among parents of children patients with AD in Taif. Regarding the utilization of TCS, we place a strong emphasis on the significant role that physicians play as sources of reliable information and proper education.

Keywords: atopic dermatitis; caregivers; steroid phobia; topical corticosteroid.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Parental Practices Toward Management of Child’s Eczema.
None
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A. Investigating international time trends in the incidence and prevalence of atopic eczema 1990–2010: a systematic review of epidemiological studies. PLoS One. 2012;7(7):7. doi:10.1371/journal.pone.0039803 - DOI - PMC - PubMed
    1. Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int. 2013;62(2):2. doi:10.2332/allergolint.13-RAI-0564 - DOI - PMC - PubMed
    1. Konstantinou GN, Konstantinou GN, Koulias C, Petalas K, Makris M. Further understanding of neuro-immune interactions in allergy: implications in pathophysiology and role in disease progression. J Asthma Allergy. 2022;15:1273–1291. doi:10.2147/JAA.S282039 - DOI - PMC - PubMed
    1. Gaspar NK, Aidé MK. Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis? An Bras Dermatol. 2016;91(4):479–488. doi:10.1590/abd1806-4841.20164211 - DOI - PMC - PubMed
    1. Lambrechts L, Gilissen L, Morren M. Topical corticosteroid phobia among healthcare professionals using the TOPICOP score. Acta Derm Venereol. 2019;99(11):1004–1008. doi:10.2340/00015555-3220 - DOI - PubMed